肠系膜上动脉狭窄的血管腔内治疗  

Endovascular therapy for superior mesenteric artery stenosis

作　　者：张希全[1] 葛世堂 

机构地区：[1]中国人民解放军第148医院全军腔内介入诊疗中心,山东淄博255300

出　　处：《中国介入影像与治疗学》2016年第11期662-664,共3页Chinese Journal of Interventional Imaging and Therapy

摘　　要：目的 探讨介入治疗肠系膜上动脉狭窄的安全性及临床疗效。方法 对12例肠系膜上动脉狭窄的患者行选择性肠系膜上动脉造影，然后行球囊扩张或支架植入治疗，评价疗效。结果 12例肠系膜上动脉狭窄的患者技术成功率100%，其中单纯球囊扩张2例，球囊扩张＋内支架植入术10例。对所有患者随访6~24个月，平均16个月，其中10例无明显症状，2例有腹痛症状，经再次腔内治疗，症状得到明显改善。随访中所有患者均未出现肠坏死、死亡等严重并发症。结论 血管腔内介入治疗肠系膜上动脉狭窄是一种安全、有效的方法。Objective To investigate the safety and efficacy of interventional treatment for the superior mesenteric artery stenosis. Methods The clinical data of 12 cases with superior mesenteric artery stenosis were retrospectively analyzed. Selective superior mesenteric artery angiography, balloon expansion or stenting treatment were performed, and the efficacy was evaluated. Results The technical success rate of 12 cases with superior mesenteric artery stenosis was 100%, including simple balloon expansion in 2 cases, balloon dilation and stenting in 10 cases. All 12 cases were followed up 6-24 months （average 16 months）, 10 cases were without obvious symptoms, 2 cases were with abdominal pain who received the interventional treatment twice and the symptoms improved significantly. In followed up, there were no serious complications of intestinal necrosis, death, etc. Conclusion Endovascular therapy is a safe and effective method for superior mesenteric artery stenosis.

关 键 词：介入治疗 肠系膜动脉 上 支架 

分 类 号：R572.3[医药卫生—消化系统]